NCER Comments: As part of an NIH randomized, placebo-controlled clinical trial, UNMC is currently studying the effects of the antiviral drug Remdesivir on COVID-19 patients. Outcomes seen as quickly as within 15 days are being monitored by a national independent safety board, and the unofficial results are positive so far. The UNMC “Quarantine Unit” (in […]